TABLE 1

Patient Data, Lesion Data, Final Diagnosis, and Imaging Results

ClassificationImaging result
Les no.Pt no.SexAge (y)NBLCHy NBDiam (cm)LocationSUVmax 3D (A)SUVmax BB 4D (B)Bin% Dif (B − A)SUVmax AG 4D (C)% Dif (C − A)3DBB 4DAG 4DHy3DBB 4DAG 4D
11M731.0LUL2.43.1229.22.712.5BMMTNFPFP
211.3LUL1.41.6114.31.57.1BBBTNTNTN
32F71YTesticular2.1LUL17.421.5214.920.517.8MMMMts melanomaTPTPTP
43F542.8LUL1.93.3673.72.742.1BMMHamartomaTNFPFP
54M68YProstate2.0RLL6.89.7642.69.235.2MMMNSCLCTPTPTP
65M78YMelanoma2.5LUL1.72.7558.81.911.7BMBFNTPFN
76F541.3LUL2.22.324.52.20BBBTNTNTN
87M601.0LLL1.82.2322.21.80BBBEpidermalFNFNFN
98M70YLarynx3.5LUL4.15.2326.84.817.0MMMTPTPTP
1082.0RUL3.02.92−3.32.7−10.0MMMTPTPTP
1181.7Lingula1.72.3235.31.70BBBFNFNFN
129M801.6RUL1.21.4116.61.416.7BBBTNTNTN
1390.8Lingula1.21.7141.61.416.7BBBTNTNTN
1410M80YYNSCLC3.2LUL22.530.3434.720.8−7.6MMMAdenocaTPTPTP
15102.0LUL2.43.1229.22.816.7BMMAdenocaFNTPTP
1611M51YYSCLC4.0RLL8.411.1232.110.727.4MMMSCLCTPTPTP
17110.9RUL1.111.0BBBSCLCFNFNFN
1812M52YYNSCLC2.1RUL2.42.618.32.40BMBAdenocaFNTPFN
1913M71YColorectal0.7ML0.81.5287.51.587.5BBBTNTNTN
20130.7RLL1.72.2329.41.85.9BBBTNTNTN
2114M73YHD1.8RUL1.21.318.31.20BBBTNTNTN
2215F73YColorectal2.4RLL10.112.7525.711.816.8MMMTPTPTP
2316M84YYEpidermoid1.6RLL3.24.8350.04.231.2MMMEpidermoidTPTPTP
2417F50YOvarian0.6RUL1.32.0153.81.730.8BBBTNTNTN
2518M58YRenal0.8RUL0.52.32360.02.3360.0BBBNegativeTNTNTN
26181.0RUL1.23.21166.73.0150.0BMMNegativeTNFPFP
27182.0RUL1.82.6453.82.433.3BMBNegativeTNFPTN
28180.8ML0.40.4BBBNegativeTNTNTN
2919M73YColorectal2.0LUL3.05.3676.74.963.3MMMTPTPTP
30190.9LUL1.22.0166.71.525.0BBBFNFNFN
31190.7RUL0.81.3162.51.137.5BBBFNFNFN
3220M650.5RUL0.41.16175.01.0150.0BBBTNTNTN
3321F61YMelanoma1.3Lingula0.51.53200.01.4180.0BBBTNTNTN
3422M70YColorectal0.9LLL2.83.4221.43.110.7MMMTPTPTP
3523M70YColorectal0.6LLL1.11.9472.71.318.2BBBFNFNFN
36231.2RLL0.92.54177.71.788.9BMBFNTPFN
3724M57YEpidermoid1.6RLL3.15.4174.24.854.8MMMTPTPTP
38241.2Lingula2.02.7335.02.420.0BMBFNTPFN
3925F61YEndometrial0.7RUL0.92.82211.12.1133.3BMBFNTPFN
40250.9RUL1.02.91190.02.7170.0BMMFNTPTP
41251.2RLL2.44.7195.83.650.0BMMFNTPTP
4226F67YYNSCLC0.8RUL0.81.93137.51.6100.0BBBTNTNTN
43260.8LLL1.42.95107.12.578.6BMMTNFPFP
4427M69YColorectal1.2LLL0.81.1137.50.912.5BBBFNFNFN
45271.0RLL1.51.7113.31.50BBBFNFNFN
4628M41YTesticular1.5RLL1.42.4571.42.150.0BBBNegativeTNTNTN
4729F68YColorectal0.8RUL1.12.52127.32.190.9BMBFNTPFN
48291.0RLL1.23.42183.32.391.7BMBFNTPFN
49290.7RLL1.23.22166.62.5108.3BMMFNTPTP
5030F79YRenal2.4LLL1.81.8201.3−27.8BBBMtsFNFNFN
5131M582.2RLL10.914.8135.813.120.2MMMEpidermoidTPTPTP
5232F57YCervix1.2RLL1.72.3235.32.123.5BBBFNFNFN
5333M81YColorectal1.0LUL1.34.24223.13.8192.3BMMFNTPTP
5434M65YRenal1.6LUL1.21.4616.71.20BBBFNFNFN
5535M61YSCLC2.2RLL4.710.24117.08.887.2MMMSCLCTPTPTP
5636M62YLarynx4.7RUL18.621.6316.120.49.7MMMPositiveTPTPTP
5737M802.4RUL2.75.2392.64.877.8MMMFPFPFP
  • Les = lesion; Pt = patient; NB = neoplastic background; LC = lung cancer; Hy = histopathology; Diam = diameter; BB = best bin; Dif = difference; AG = average gated; NSCLC = non–small cell lung cancer; SCLC = small cell lung cancer; HD = Hodgkin disease; RUL: right upper lobe; LUL = left upper lobe; RLL = right lower lobe; LLL = left lower lobe; ML = middle lobe; B = benign; M = malignant; Mts = metastases; adenoca = adenocarcinoma; TN = true negative; FP = false positive; TP = true positive; FN = false negative.